Ultrasound can accurately predict elevated intracranial pressure, according to a study presented at the 2005 American Institute of Ultrasound in Medicine meeting.
Ultrasound can accurately predict elevated intracranial pressure, according to a study presented at the 2005 American Institute of Ultrasound in Medicine meeting.
Prompt detection of increased intracranial pressure (ICP) in unconscious trauma patients may help emergency physicians make critical management decisions, sort out treatment priorities, and avoid unnecessary tests. ICP can signal or lead to several neurologic conditions:
The clinical literature points at CT as the standard of care for ICP diagnosis. Dr. Vivek Tayal and colleagues at the Carolinas HealthCare System in Charlotte, however, hypothesized that ultrasound measurement of the optic nerve sheath diameter (ONSD) could anticipate CT findings.
The investigators applied the technique on 55 patients with head trauma prospectively enrolled in the study. They found that ultrasound gauging of the ONSD correctly predicted all cases of increased ICP diagnosed by CT.
The researchers applied a 7.5-MHz ultrasound probe on the closed eyelids of all subjects and evaluated the ONSD 3 mm behind the globe. An ONSD of 5 mm or greater was considered abnormal.
All seven patients who showed signs correlating with elevated ICP on CT also showed a mean ONSD of 6.27 mm. Bedside ultrasound for ICP detection with an ONSD cutoff of 5.5 mm showed a sensitivity, specificity, and positive predictive value of 100%, 86.4%, and 53.9%, respectively.
Bedside ONSD ultrasound could become a helpful screening test for the diagnosis of elevated ICP, especially considering that the clinical assessment of ICP may be unreliable, the investigators said.
For more information from the Diagnostic Imaging archives:
Ultrasound streamlines emergency medicine
Studies explore strategies for emergency room MSCT
Underserved areas ring up for long-distance ultrasound interpretation
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.